Ole Poulsen - Red Violet Chief Science Officer
RDVT Stock | USD 38.78 0.67 1.76% |
Executive
Mr. Ole Poulsen is Chief Science Officer of the Company since March 2018. He has served as Chief Science Officer of red violet since the March 2018 spinoff from information and digital performance marketing solutions provider, cogint. Mr. Poulsen served as the Chief Science Officer of cogint prior to the spinoff of red violet since 2018.
Tenure | 6 years |
Address | 2650 North Military Trail, Boca Raton, FL, United States, 33431 |
Phone | 561 757 4000 |
Web | https://www.redviolet.com |
Red Violet Management Efficiency
The company has return on total asset (ROA) of 0.043 % which means that it generated a profit of $0.043 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0559 %, meaning that it created $0.0559 on every $100 dollars invested by stockholders. Red Violet's management efficiency ratios could be used to measure how well Red Violet manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.27 in 2024. Return On Capital Employed is likely to gain to 0.03 in 2024. At this time, Red Violet's Non Current Liabilities Other is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 2.5 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 4.7 M in 2024.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Kayla JD | Meridianlink | N/A | |
David Knight | Rego Payment Architectures | 59 | |
Alton Ing | RIWI Corp | N/A | |
Mark Lloyd | Issuer Direct Corp | 60 | |
Frank Buckley | Research Solutions | N/A | |
Marc Nissan | Research Solutions | 47 | |
Shelly JD | Envestnet | 58 | |
P Mozumder | PDF Solutions | 61 | |
Bradley Herring | Enfusion | 53 | |
Kayla Dailey | Meridianlink | N/A | |
Matthew Campobasso | Enfusion | 45 | |
Doug Piper | Meridianlink | N/A | |
Gianna Rotellini | Meridianlink | N/A | |
Ignatius Njoku | Enfusion | N/A | |
Alan CPA | Research Solutions | 56 | |
Andrew Stavaridis | Envestnet | N/A | |
Shelly OBrien | Envestnet | 54 | |
Richard Aneser | Envestnet | N/A | |
Farouk Ferchichi | Envestnet | N/A | |
Steven Knerr | Issuer Direct Corp | 48 | |
Danielle Goldfarb | RIWI Corp | N/A |
Management Performance
Return On Equity | 0.0559 | ||||
Return On Asset | 0.043 |
Red Violet Leadership Team
Elected by the shareholders, the Red Violet's board of directors comprises two types of representatives: Red Violet inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Red. The board's role is to monitor Red Violet's management team and ensure that shareholders' interests are well served. Red Violet's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Red Violet's outside directors are responsible for providing unbiased perspectives on the board's policies.
James Frasche, Ex Solutions | ||
Jeffrey Dell, Chief Officer | ||
Angus Macnab, Chief Officer | ||
Joshua Weingard, Corporate Secretary | ||
Jonathan McDonald, Executive Sector | ||
Jacky Wang, Chief Officer | ||
Ole Poulsen, Chief Science Officer | ||
Daniel MacLachlan, Chief Officer | ||
James Reilly, President | ||
Camilo Ramirez, IR Contact Officer | ||
Derek Dubner, Interim Chairman of the Board, CEO |
Red Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Red Violet a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0559 | ||||
Return On Asset | 0.043 | ||||
Profit Margin | 0.07 % | ||||
Operating Margin | 0.13 % | ||||
Current Valuation | 492 M | ||||
Shares Outstanding | 13.79 M | ||||
Shares Owned By Insiders | 25.26 % | ||||
Shares Owned By Institutions | 60.35 % | ||||
Number Of Shares Shorted | 687.52 K | ||||
Price To Earning | 156.82 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Red Stock Analysis
When running Red Violet's price analysis, check to measure Red Violet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Red Violet is operating at the current time. Most of Red Violet's value examination focuses on studying past and present price action to predict the probability of Red Violet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Red Violet's price. Additionally, you may evaluate how the addition of Red Violet to your portfolios can decrease your overall portfolio volatility.